[
  {
    "ts": null,
    "headline": "J&J Adds More Than $15B in Six Months: How to Play JNJ Stock?",
    "summary": "JNJ stock added $15B in market value in six months as new drug launches offset MedTech and Stelara headwinds.",
    "url": "https://finnhub.io/api/news?id=7ed278cf006eb3e3a9dbfc23c4678d28e3d998b349c14b34995012709b919acc",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750684920,
      "headline": "J&J Adds More Than $15B in Six Months: How to Play JNJ Stock?",
      "id": 135481691,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "KVUE",
      "source": "Yahoo",
      "summary": "JNJ stock added $15B in market value in six months as new drug launches offset MedTech and Stelara headwinds.",
      "url": "https://finnhub.io/api/news?id=7ed278cf006eb3e3a9dbfc23c4678d28e3d998b349c14b34995012709b919acc"
    }
  },
  {
    "ts": null,
    "headline": "When Should You Buy Kenvue Inc. (NYSE:KVUE)?",
    "summary": "Today we're going to take a look at the well-established Kenvue Inc. ( NYSE:KVUE ). The company's stock received a lot...",
    "url": "https://finnhub.io/api/news?id=9700f0ef1e5613724ff4635ba27dc6471b6db97c63e0b32c8f5b684c9c902614",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750677635,
      "headline": "When Should You Buy Kenvue Inc. (NYSE:KVUE)?",
      "id": 135482251,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "KVUE",
      "source": "Yahoo",
      "summary": "Today we're going to take a look at the well-established Kenvue Inc. ( NYSE:KVUE ). The company's stock received a lot...",
      "url": "https://finnhub.io/api/news?id=9700f0ef1e5613724ff4635ba27dc6471b6db97c63e0b32c8f5b684c9c902614"
    }
  },
  {
    "ts": null,
    "headline": "KVUE- A Beauty Care Turnaround Play Mulling Key Moves",
    "summary": "As part of its broader restructuring efforts, Kenvue Inc. (KVUE) is considering the sale of some of its skin health and beauty brands. KVUE is currently rated a “Buy” in the portfolio, highlights Clif Droke, editor of Cabot Turnaround Letter.",
    "url": "https://finnhub.io/api/news?id=76f1c90fec0a29564416ba926c8e794417aba8d5bb1ed7076977e69032c9e526",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750654860,
      "headline": "KVUE- A Beauty Care Turnaround Play Mulling Key Moves",
      "id": 135492489,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "KVUE",
      "source": "Yahoo",
      "summary": "As part of its broader restructuring efforts, Kenvue Inc. (KVUE) is considering the sale of some of its skin health and beauty brands. KVUE is currently rated a “Buy” in the portfolio, highlights Clif Droke, editor of Cabot Turnaround Letter.",
      "url": "https://finnhub.io/api/news?id=76f1c90fec0a29564416ba926c8e794417aba8d5bb1ed7076977e69032c9e526"
    }
  }
]